Skip to content
The Policy VaultThe Policy Vault

Cabometyx (cabozantinib tablets) — Cigna

Pheochromocytoma/Paraganglioma

Initial criteria

  • Patient age ≥ 18 years
  • Patient has locally unresectable disease

Approval duration

1 year